Q9UGN5 (PARP2_HUMAN) Homo sapiens (Human)

Poly [ADP-ribose] polymerase 2 UniProtKBInterProSTRINGInteractive Modelling

583 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

25 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Bridging of double-strand DNA break activates PARP2/HPF1 to modify chromatin Heteromer
Q9NWY4;
90-583
100.0
Bridging of double-strand DNA break activates PARP2/HPF1 to modify chromatin Heteromer
P02281; P06897; P62799; P84233; Q9NWY4;
90-583
100.0
Bridging of double-strand DNA break activates PARP2/HPF1 to modify chromatin Heteromer
Q9NWY4;
90-583
100.0
HPF1 bound to catalytic fragment of PARP2 Heteromer
Q9NWY4;
323-583
17.65UHB;
Structure of two nucleosomes bridged by human PARP2 Heteromer
P04908; P06899; P62805; P68431;
92-205
98.25
Crystal Structure NLS from human PARP-2 complexed with Importin alpha delta IBB Heteromer
P52293;
19-41
100.0
Structure of ARTD2/PARP2 WGR domain bound to double strand DNA without 5'phosphatehomo-6-mer91-209
100GOL;CL;
Human ARTD2 in complex with DNA oligonucleotideshomo-2-mer91-583
100.0SO4;
Structure of ARTD2/PARP2 WGR domain bound to double strand DNA with 5 nucleotide overhang and 5'pho…homo-2-mer92-207
100
Structure of ARTD2/PARP2 WGR domain bound to double stranded DNA with 5'phosphatehomo-2-mer92-205
100
Structure of PARP2 catalytic domain bound to an isoindolinone inhibitormonomer231-583
100.0FSU;
Structure of human PARP2 catalytic domain bound to an isoindolinone inhibitormonomer231-583
100.0D7N;
Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to Rucaparibmonomer230-581
98.86GOL;RPB;
Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to approved drug Fluzoparibmonomer230-581
98.86GOL;25I;
Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to Niraparib (MK-4827)monomer230-581
98.86GOL;3JD;
Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to Pamiparib(BGB-290)monomer230-581
98.86GOL;DS9;
Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to a pyrazolopyrimidine carbo…monomer230-581
98.86ERV;
Human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inh…monomer231-581
98.86GOL;1WI;
Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to Olaparib (AZD2281)monomer230-579
98.8609L;
Human poly(ADP-ribose) polymerase 2, catalytic fragment in complex with an inhibitor ABT-888monomer235-579
99.7178P;GOL;
PARP2 catalytic domain in complex with OUL245monomer235-579
99.71GOL;I5F;
Human poly(ADP-ribose) polymerase 2, catalytic fragment in complex with an inhibitor 3-aminobenzami…monomer235-579
99.713AB;GOL;
HUMAN ARTD2 (PARP2) - CATALYTIC DOMAIN IN COMPLEX WITH OLAPARIBmonomer235-579
99.7109L;GOL;
Structure of PARP2 catalytic domain bound to inhibitor BMN 673monomer235-579
99.72YQ;GOL;
Crystal structure of constitutively active PARP-2monomer352-581
100UHB;

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6x0l.1.Bmonomer0.7690-583
100.00
6tx3.1.Amonomer0.75319-583
UHB;91.15

2 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26x0l.1.Bmonomer0.7977-570
100.00
Isoform 26tx3.1.Amonomer0.75306-570
UHB;91.15